Search results for: CeQur

Need a new search

If you didn't find what you were looking for, try a new search!

Interview with Bradley Paddock on CeQur Simplicity

In just over a year, CeQur® has reached major milestones in financing, company growth and the pilot launch of its three-day insulin delivery device for type 2 diabetes, CeQur Simplicity™. In this interview, CEO Bradley Paddock explains how the company is [...]

2023-04-03T11:12:07+01:00June 15th, 2022|

CeQur Appoints Rick Doubleday and Dr Meret Gaugler to Board of Directors

Accomplished executives with decades of healthcare experience join board as CeQur Simplicity™ advances toward commercialization LUCERNE, Switzerland & MARLBOROUGH, Mass.— (BUSINESS WIRE) — CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today [...]

2023-03-29T08:55:53+01:00June 28th, 2021|

CeQur Raises $115 Million Series C5 Financing

CeQur Raises $115 Million Series C5 Financing Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led by Credit Suisse [...]

2022-01-27T22:12:23+00:00April 15th, 2021|

Interview with Bradley Paddock, CEO of CeQur

In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes.  [...]

2023-04-03T16:01:27+01:00January 6th, 2020|

CeQur appoints Bradley Paddock Chief Executive Officer

Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech [...]

2023-04-12T12:40:58+01:00June 6th, 2019|
Go to Top